CompletedPhase 2NCT00003907
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Studying Adult hepatocellular carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eastern Cooperative Oncology Group
- Principal Investigator
- Keith E. Stuart, MD, M.D., Ph.DBeth Israel Deaconess Medical Center
- Intervention
- cisplatin(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1999 – 2012
Study locations (30)
- Front Range Cancer Specialists, Fort Collins, Colorado, United States
- Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States
- Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (Decatur), Decatur, Georgia, United States
- Rush-Copley Cancer Care Center, Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois, United States
- Hematology and Oncology Associates, Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States
- Mercy Hospital and Medical Center, Chicago, Illinois, United States
- Swedish Covenant Hospital, Chicago, Illinois, United States
- Hinsdale Hematology Oncology Associates, Hinsdale, Illinois, United States
- Midwest Center for Hematology/Oncology, Joliet, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States
- North Shore Oncology and Hematology Associates, Limited - Libertyville, Libertyville, Illinois, United States
- Hematology Oncology Associates - Skokie, Skokie, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003907 on ClinicalTrials.govOther trials for Adult hepatocellular carcinoma
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT07441369Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases CancerFudan University
- RECRUITINGPHASE2NCT07175441Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular CarcinomaRiboscience, LLC.
- RECRUITINGPHASE2NCT07560488Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular CarcinomaTianjin Medical University Cancer Institute and Hospital
- RECRUITINGPHASE1, PHASE2NCT07291076A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Bristol-Myers Squibb
- RECRUITINGPHASE2NCT07010497A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular CarcinomaAsan Medical Center
- RECRUITINGPHASE1, PHASE2NCT07500220Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCCBeijing Biotech
- RECRUITINGPHASE2NCT07413354Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular CarcinomaTongji Hospital
- RECRUITINGNANCT07365527Sonoporation and Tumor Microenvironment Response in Colorectal Liver MetastasesZealand University Hospital